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Abstrad
Conditioned medium from cultures of HL-60 myeloid
leukemia cells grown on extracellular bone marrow
matrix induces macrophage-like differentiation of fresh
HL-60 cells. The adive medium component is sensitive
to protease treatment, indicating that it is a protein, but
it is heat stable. Conditioned medium from HL-60 cells
grown on protease-treated bone marrow matrix still
contains the adive component. Thus, it appears that
the differentiation-inducing protein is produced by
HL-6O cells and is not released from the bone marrow
matrix. To identify this differentiation fador, RNA was
isolated from HL-60 cells grown on bone marrow
matrix and assayed by Northern analysis for expression
of mRNA for human differentiation fador, tumor
necrosis fador, and macrophage colony-stimulating
fador, all inducers of monocyte/macrophage
differentiation. Expression of differentiation fador,
tumor #{224}ecrosis fador, or macrophage colony-
stimulating fador mRNA was not enhanced in HL-6O
cells grown on matrix compared to cells grown on
uncoated plastic flasks. Thus, the maturation fador
does not appear to be differentiation fador, tumor
necrosis fador, or macrophage colony-stimulating
fador within the limits of detedion of Northern
analysis. Elution of the adive conditioned medium
fradion on a Sephacryl S-200 column revealed a
molecular weight of approximately 40,000. The adive
protein eluted on a DEAE-cellulose ion-exchange
column at an ionic strength of 0.3 M NaCI, indicating
that it is fairly anionic. Thus, bone marrow matrix is
able to induce HL-60 cells to produce a maturation-
inducing 40 kilodalton protein. This protein has
biochemical properties different from those of
previously described physiological inducers of
monocyte differentiation, suggesting that it is a novel
differentiation fador.
Introdudion
The human myeloid leukemia cell line HL-60 is often
used as a model system to study terminal differentiation
in myeloid cells. Various lymphokines and cytokines are
known to cause physiological induction of differentiation
of these cells along the monocyte/macrophage pathway.
We have previously reported that HL-60 cells grown on
human bone marrow stroma extracellular matrix or a
heparan sulfate-containing matrix fraction express a ma-
ture macrophage-like phenotype (1, 2). Furthermore,
CM3 from cocultures of HL-60 cells and bone marrow
stromal cells has been shown to alter the phenotype of
other HL-60 cells, whereas stromal cell-CM does not (1).
It appears that the stroma-exposed leukemic cells pro-
duce and/or release active factors from the stroma into
the medium. It has previously been reported that CM
from dimethyl sulfoxide-treated or 1,25-dihydroxyvi-
tamin D3-treated HL-60 cells induces monocytic differ-
entiation in fresh HL-60 cells (3). Thus, HL-60 cells appear
to be capable of autonomously producing a differentia-
tion factor (3). Our results of enzymatic degradation of
the stromal matrix, presented here, suggest that bone
marrow matrix induces HL-60 cells to produce an auton-
omous monocytic differentiation factor.
Physiologically produced substances with monocyte/
macrophage differentiating capabilities include human
DF, also known as differentiation-inducing factor (4), TNF
(5), and M-CSF (6). DF is produced by mononuclear
blood cells after stimulation with various mitogens (4). It
stimulates HL-60 cells to differentiate into cells with
granulopoietic or myelomonocytic characteristics (4).
Macrophages (7) and differentiated HL-60 cells (8) se-
crete TNF, which, in addition to being a monocytic
differentiation factor for HL-60 cells (5), is known to have
antiproliferative effects on HL-60 (8) and other tumor
cells (9). TNF also induces the gene expression of M-CSF
by HL-60 cells (10) and M-CSF secretion by monocytes
(11). M-CSF, also known as CSF-i, has various effects,
including the stimulation of hematopoietic stem cells to
form macrophages and monocytes (6). We have exam-
med the expression of mRNA for these three cytokines,
DF, TNF, and M-CSF, in HL-60 cells grown on bone
marrow matrix. We also characterized the active CM
component as a heat-stable protein of approximately 40
kilodaltons which elutes from a DEAE-cellulose ion-ex-
change column at 0.3 M NaCI. Thus, the biochemical
properties of this HL-60 cell differentiation factor distin-
guish it from previously described cytokines.
Results
CM was harvested from HL-60 cells grown on human
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Table 1 Effects of treatment on differentiating activity in conditioned
medium
Treatment of CM
% of Controla
Fc rosettes Esterase
iocrcforiomin 93 100
12s￿cfor4smin 66 93
ProteinaseK 16b
38b
Pronase 8b
24b
Trypsin
7b 8b
a cells were collected 72 h after seeding and were assayed. Each value is
the average of a minimum of 200 cells scored from duplicate flasks from
two independent experiments with <7% deviation between flasks and
with the value of untreated (in the case of heating) or boiled (in the case
of the proteases) taken as 100%.
b Significantly different from control, P < 0.05.
bone marrow stromal matrix. To characterize the matu-
ration-md ucing CM component, aliquots of concentrated
CM were untreated or were denatured by boiling for 5
mm and then treated with Proteinase K, Pronase, or
trypsin for 18 h at 37#{176}C, or heated to 100#{176}C for 10 mm
or 125#{176}C for 45 mm. HL-60 cells were grown for 3 days
in the presence of untreated or treated CM concentrates,
and differentiation was assessed by nonspecific esterase
activity and Fc rosette formation. As shown in Table 1,
heat did not significantly reduce activity. In contrast, all
three protease treatments significantly reduced the abil-
ity of CM to induce these differentiation markers. Matu-
ration was corroborated in the cells grown in the un-
treated or heat-treated CM samples by morphological
assessment of the presence of cytoplasmic vacuolation,
irregularity of the cytoplasmic borders, and a decrease in
the nuclear:cytoplasmic ratio.
To determine whether the source of the active CM
component was the extracellular matrix or the HL-60
cells, the maturation-inducing heparan sulfate fraction of
bone marrow stroma was isolated by ion-exchange chro-
matography and gel electrophoresis (2) and then treated
with Proteinase K to inactivate any contaminating pro-
teins. It was subsequently dried onto tissue culture wells
and incubated with HL-60 cells. The CM from these
cultures was removed, precipitated with 50% ammonium
sulfate, concentrated, and added to fresh HL-60 cells.
These cells were then assessed for maturation. As shown
in Table 2, these HL-60 cells expressed a mature phe-
notype, as measured by nonspecific esterase activity and
the ability to induce Fc rosettes when grown in the
presence of CM from the purified protease-treated ma-
trix. Morphological maturation was also induced. Yet,
protease treatment of the CM still abrogated maturation
induction. Thus, the active protein appears to be pro-
duced by HL-60 cells.
The effect of this differentiation-inducing CM compo-
nent on HL-60 cell proliferation was measured next (Fig.
1). After 6 days in culture, cell numbers were significantly
(P < 0.05) decreased by approximately 20% in flasks
containing conditioned medium. Thus, the more mature
phenotype induced by this factor was accompanied by
a restriction of proliferation.
HL-60 cells grown on bone marrow matrix were ana-
lyzed for mRNA for various physiological inducers of
macrophage differentiation. Fig. 2 is an autoradiogram of
an RNA blot tested for TNF expression. HL-60 cells grown
Table 2 HL-60 cells grown in conditioned medium from HL-60 purified
matrix cultures
Treatment
(Matrix/CM)
% positivea
Esterase Fc rosettes
None/none
Protease/none
Protease/protease
93
91
2ii￿
41
43
i0￿)
a Cells were collected 72 h after seeding and were assayed. Each value is
the average of a minimum of 200 cells scored from duplicate flasks from
two independent experiments with <10% deviation between flasks.
Controls grown on uncoated plastic were scored as 1% positive for
esterase activity and 8% positive for Fc rosette induction.
b Significantly different from untreated CM, P < 0.05.
on uncoated plastic flasks showed a constitutive expres-
sion of TNF mRNA. Their expression did not increase
with exposure to the extracellular matrix, in contrast to
the increase observed after treatment with TPA. Fig. 3
demonstrates an autoradiogram of a Northern blot of
poly(A)￿ RNA tested for DF expression. Peripheral blood
lymphocytes treated with PHA for 1 week showed
expression of DF. HL-60 cells grown on the extracellular
matrix showed no expression, similar to those grown on
plastic. The autoradiogram shown in Fig. 4 is of a RNA
blot tested for M-CSF expression. Only the WI 38 fibro-
blast cell line demonstrated expression of M-CSF mRNA.
Thus, the HL-60 cells grown on matrix do not appear to
be producing TNF, DF, or M-CSF.
To further characterize the CM differentiation factor,
aliquots were eluted on a Sephacryl S-200 column, as
demonstrated in Fig. 5. The fractions which produced a
more mature phenotype in HL-60 cells eluted in the
30,000-40,000 molecular weight range. Differentiation
activity was again measured by morphology, nonspecific
esterase activity, and Fc rosette formation. All three mark-
ers had similar results.
The CM was isolated from cultures of HL-60 cells
grown on bone marrow extracellular matrix in which the
HL-60 cells were labeled with [3H}leucmne to monitor
their protein production. The medium was concentrated
and applied to a Sephacryl 5-200 column. Active fractions
were pooled, concentrated, applied to a DEAE-cellulose
ion-exchange column, and eluted with a 0.01 -0.4 M
linear gradient, as demonstrated in Fig. 6. The matura-
tion-mnducing activity comigrated with [3H]leucine-radi-
olabeled material at an ionic strength of 0.3 M NaCI. This
suggests that the maturation-inducing protein is anionic.
Discussion
We have shown that the CM from cultures of HL-60 cells
grown on bone marrow matrix or a heparan sulfate matrix
fraction has the ability to differentiate fresh HL-60 cells.
Our data suggest that this maturation-inducing activity is
due to a protein molecule produced and secreted by
matrix-stimulated HL-60 cells. Several points suggest that
the active CM component is not a matrix component
that is released in the presence of the HL-60 cells. First,
the heparan sulfate matrix fraction was isolated by ion-
exchange chromatography in the presence of a high salt
concentration which should have dissociated any bound
growth factors (12, 13). Furthermore, the activity of the
CM was susceptible to protease treatment, whereas theC-)
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Fig. 1. Effect of CM on the replication of HL-60 cells. HL-60 cells were
plated at a density of 1 x l0￿ cells/mI in the presence (0) or absence (U)
of concentrated CM in PBS. Control flasks received an equal volume of
PBS. Each point, mean of duplicate flasks with less than 10% deviation
between flasks.
maturation-inducing activity ofthe heparan sulfate matrix
was not (2). In the present study, CM from HL-60 cells
grown on heparan sulfate which had been treated with
protease to digest any contaminating proteins still con-
tamed the maturation-inducing protein. Although
glycosaminoglycans can protect bound proteins from
inactivation (14), our protease treatment conditions were
quite severe at 55#{176}C for 18 h. Thus, it is unlikely that the
CM protein that induces maturation of fresh HL-60 cells
was released from the matrix. We conclude that the
heparan sulfate fraction of bone marrow matrix induces
HL-60 cells to produce an autocrine differentiation
factor.
This factor differs in biochemical properties from pre-
viously described inducers of monocytic differentiation.
It is a very anionic, heat-stable protein of approximately
40 kilodaltons. Three other inducers of monocytic differ-
entiation, DF, TNF, and M-CSF, were shown by Northern
analysis not to be induced in HL-60 cells grown on matrix.
Although these factors have been shown by gel filtration
chromatography to have molecular weights fairly similar
to this active protein-55,000 (15), 45,000 (16), and
50,000 (1 7) for DF, TNF, and M-CSF, respectively, they
are all heat sensitive and not as highly charged (15, 16,
18-20). On a DEAF-cellulose ion-exchange column, they
elute at 0.1, 0.15, and 0.13 M NaCI, respectively. Other
inducers of monocytic differentiation include lympho-
toxin (5), rny-interferon (21), and interleukins 1 (22), 3 (23),
and 6 (24). Lymphotoxin (5) and -y-interferon (21) are
produced by lymphoid, not myeloid, cells. Interleukin 1
acts only indirectly to induce monocytic differentiation
(22). As shown by gel filtration chromatography, these
factors have molecular weights of 60,000 (25), 58,000
(26), 13,000 (27), 25,000-40,000 (28), and 26,000 (29),
respectively. Lymphotoxin elutes on a DFAE-cellulose
ion-exchange column at 0.1 M NaCI (25). ‘y-lnterferon
has an isoelectric point of 8.6 (26). Interleukin 1 and
interleukin 3 do not bind to DEAF-cellulose (27, 28).
Interleukin 6 elutes at 0.15 M NaCI and is heat labile (30,
31). Granulocyte/macmophage colony-stimulating factor
induces expression of macrophage membrane antigens
actin
Fig. 2. TNF mRNA levels in HL-60 cells grown on plastic or bone marrow
matrix. Each lane was loaded with 20 ￿g total RNA. TPA-tmeated HL-60
cells were the positive control. Hybridization was performed by using
TNF-a and ￿-actin probes. kb, kilobases.
but does not induce morphological maturation of HL-60
cells (32) and differs in biochemical properties from this
CM protein (33).
As previously reported by Djulbegovic et a!. (3), CM
from dimethyl sulfoxide-treated or 1,25-dihydroxyvi-
tamin D3-treated HL-60 cells induces monocytic differ-
entiation and inhibition of soft agar clonogenicity in fresh
HL-60 cells. Since this CM contained no detectable ‘y-
interferon or GM-CSF activity, neither was felt to be the
differentiating CM component. The biochemical prop-
erties of this active CM component were not further
characterized.
Our laboratory has previously reported that a heparan
sulfate bone marrow matrix fraction induces HL-60 cell
maturation (2). Whether the heparan sulfate alone is
directly responsible for these effects or whether it acts
indirectly by stimulating the production of this novel
diffusible factor will be investigated. It will also be of
interest to study the mole of this novel factor in the
differentiation of other leukemic and normal blood cells.
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actin
11g. 3. DF mRNA levels in HL-60 cells grown on plastic or bone marrow
matrix. Each lane was loaded with 1 ￿ig poly(A)￿ RNA. PHA-stimulated
peripheral blood mononuclear cells were the positive control. Hybridi-
zation was performed by using DF and ￿y-actin probes. kb, kilobases.
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Materials and Methods
Cell Culture. A bone marrow stromal cell line previously
established in this laboratory (1) was grown to confluence
in 25-cm2 tissue culture flasks containing RPMI 1640
supplemented with 15% heat-inactivated FCS and 50 ￿zg/
ml gentamicin (GIBCO, Grand Island, NY). After 6 days
in stationary culture, the adherent layer was washed with
PBS, and exposed to 1.0% Triton X-100 (v/v) for 30 mm
at room temperature, and subsequently washed with PBS
to remove remaining nuclei and cytoskeletal elements
from the extracellular matrix (34). HL-60 cells (1 x i0￿/
ml) were seeded on the matrix-coated flasks and grown
for 3 days. CM was then harvested by removing the cells
in suspension, centrifuging at 200 x g for 4 mm, and
collecting the supemnatant. The cell pellet was resus-
pended in PBS; the flasks were washed with PBS and
incubated with 0.2 mt￿i EDTA at 37#{176}C for 3 mm. Adherent
cells were removed with a cell scraper and rescued with
RPMI medium and supplements. The flasks were again
washed with PBS, and all cells were pooled and centri-
fuged. As a control, HL-60 cells were also grown in
Fig. 4. A, M￿CSF mRNA levels in Hl.-60 cells grown on plastic or bone
marrow matrix. The WI 38 fibroblast cell line was used as a positive
control. Hybridization was performed by using a M-CSF probe. Each lane
was loaded with 2 ￿g poly(A)￿ RNA and contained equal amounts of
ethidium bromide staining (B). An absence of ethidium bromide fluores-
cence is noted at the location of the dye front. The presence of the 285
rRNA band is due to incomplete removal during poly(A)￿ RNA extraction.
kb, kilobases.
uncoated plastic tissue culture flasks for 3 days. Cell
numbers were determined using a model ZF Coulter
particle counter (Hialeah, FL).
Positive control cultures were established for measur-
ing mRNA. Since TPA-treated HL-60 cells express high
levels of TNF mRNA (35), some HL-60 cell cultures were
treated with TPA (100 nM) for 3 days. The WI 38 human
lung fibroblast cell line is known to constitutively express
M-CSF mRNA (36). These cells were grown in minimum
essential medium a medium (GIBCO), supplemented
with 10% FCS, 50 ag/mI streptomycin sulfate, and 50
units/mI penicillin G. Peripheral blood mononuclear cells
were obtained from the blood of healthy donors by0
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Fig. 5. Gel filtration chromatography of the CM on a Sephacryl 5-200
column. The elution positions of molecular weight standards are indicated
with sizes in kilodaltons. Fractions were collected, filtered for sterility,
and added to fresh HL-60 cells, which were incubated for 3 days and
tested for maturation by ability to form Fc rosettes. The fractions contain-
ing absorbance at OD 280 detecting protein content (-) and those
containing maturation-inducing activity (- - -) are indicated.
sedimentation in a Ficoll-Hypaque discontinuous density
gradient. They were grown in minimum essential medium
a medium supplemented with 20% FCS and 1% PHA, at
a density of 1 x 106 cells/mI. Cells thus treated for 1
week were the positive control for DF mRNA (4).
Assessment of Conditioned Medium-induced Differ-
entiation. HL-60 cells were seeded into CM at a density
of 1 X i 05/ml and grown for 3 days. Maturation of
HL-60 cells grown in this conditioned medium was
determined, as measured by nonspecific esterase activity
(37), Fc rosette formation (38, 39), and Wright-Giemsa
staining. Morphological maturation was assessed by the
presence of cytoplasmic vacuolation, irregularity of the
cytoplasmic borders, and a decrease in the nu-
clear:cytoplasmic ratio. CM was then precipitated with
varying concentrations of ammonium sulfate (40). The
50% pellet was found to have the maximum effect on
HL-60 phenotype. Precipitate from each flask was resus-
pended, then concentrated on a Mr 10,000 Amicon mem-
brane, brought up in PBS, filtered using 0.22-izm Millex-
CV filters (Millipore, Bedford, MA), and added in a 1-mI
volume to each flask of fresh HL-60 cells. These were
grown for 3 days, harvested, counted, and assayed for
maturation. One ml of PBS was added to control flasks.
The effect on the rate of proliferation was ascertained by
harvesting cells from companion flasks at various time
points.
Biochemical Properties of the Adive Molecule. The
effects of heat and protease treatment on the active
component were determined. The CM precipitated with
50% ammonium sulfate was resuspended in PBS. Some
aliquots were autoclaved (125#{176}C) for 45 mm; other me-
dium samples were boiled for S mm to denature the
protein and incubated with 2 mg/mI Proteinase K or
Pronase (Boehringer Mannheim, Indianapolis, IN) or tryp-
sin (GIBCO) at 37#{176}C for 18 h, and then boiled for 5 mm,
to inactivate the enzyme. Some controls were incubated
at 37#{176}C for 18 h and boiled for 10 mm. Differentiating
activity remaining after treatment was assessed.
Fig. 6. Elution on a DEAE-cellulose ion-exchange column of the active
CM fractions from gel filtration chromatography. This CM was isolated
from [3HJleucine-radiolabeled HL-60 cells grown on bone marrow matrix.
The DEAE-cellulose column (150 x 21.5 mm) was equilibrated with 0.01
M NaCI in 0.01 M sodium phosphate, pH 7, and eluted with a 0.01 -0.4 M
NaCI linear gradient. Arrows demarcate the range of fractions containing
maturation-inducing activity. #{149}, xi NaCI; 0, CPM.
Isolation of Bone Marrow Heparan Sulfate. Bone mar-
row stromal cells were seeded at 1 X 105/mI in Joklik-
modified minimum essential medium (GIBCO) supple-
mented with 15% heat-inactivated FCS and 50 ￿zg/ml
gentamicin-0.05 mM sodium sulfate. On day 3 of culture,
40 zCi/ml [35S]sulfate (1 Ci/mmol; ICN Biomedicals, Inc.,
Costa Mesa, CA) were added to the medium. On day 7,
the medium was removed, and cells were removed with
1.0% Triton X-l00 and extensive PBS washes. Radiola-
beled extracellular matrix material was harvested from
the flasks with 0.2% SDS treatment at 37#{176}C for 1 h,
precipitated with 4 volumes of absolute ethanol, resus-
pended, and applied to a DEAE-Sephacel column (2).
The radiolabeled fraction was isolated by washing with
1.5 M LiCI in 0.05 M Tris/HCI-7 M urea-lO mr￿i dithiothre-
itol, pH 6.8, and eluting in 1.5 M LiCl and 7.5% SDS in
the same buffer. The material was again precipitated in
ethanol, and after resuspension, the detergent was re-
moved on an Extracti-Gel D column. The material was
dialyzed against water, then electrophoresed on a poly-
acrylamide-agarose (1 .8:0.6%) gel. The separated frac-
tions were transferred to DEAE-cellulose paper and
eluted with 1.5 M LiCI and 7.5% SDS. Aliquots of the
active radiolabeled fraction were precipitated and resus-
pended, and the detergent was removed and then di-
alyzed extensively against water. The active fraction was
identified as heparan sulfate by its susceptibility to
heparitinase digestion. The heparan sulfate matrix frac-
tion was then boiled for 5 mm to denature any proteins
present, treated with 2 mg/mI Proteinase K at 55#{176}C for
18 h, and then boiled again for S mm to denature the
enzyme. Control preparations were boiled and incubated
at 55#{176}C for 18 h. The material was then air dried onto
tissue culture wells. HL-60 cells (1 x i05/ml) were seeded
onto the dried material and grown for 3 days, and the
CM was harvested as described. These CM samples were
added to cultures of HL-60 cells, and the maturation-
inducing activity was assessed. Some aliquots were pre-
cipitated, resuspended, and treated with Proteinase K as
described.642 Novel Differentiation Factor Produced by HL-60 Cells
Northern Analysis. Total cellular RNA was isolated
from cells using the RNAzol method (Cinna-Biotecx,
Friendswood, TX) (41). Poly(A)” RNA was also extracted
using the Fast-Track mRNA Isolation method (Invitrogen
Corp., San Diego, CA).
The purified RNA was analyzed by electrophoresis
through 1% agarose-formaldehyde gels (42) followed by
Northern transfer to Nytran paper (Schleicher and
Schuell, Keene, NH). The RNA was covalently cross-
linked to the Nytran filters using UV light, and the filters
were then prehybridized at 42#{176}C for 16-20 h in a buffer
consisting of 6X SSPE (1 x SSPE: 2.98 M sodium chloride-
0.2 M sodium phosphate-0.022 M EDTA), lox Denhardt’s
solution [lx Denhardt’s: 1% (w/v) Ficoll-1% (w/v) poly-
vinyl pyrrolidone-1% (w/v) bovine serum albumin], 0.5%
SDS, and 50 ￿ig/ml denatured herring sperm DNA. The
filters were then hybridized for 16-20 h in buffer con-
sisting of 6X SSPE-0.5% SDS-50% formamide and 50 ag/
ml denatured herring sperm DNA, with 1 x 106 cpm/mI
of denatured, labeled probe. After hybridization, the
filters were washed twice in 2x SSPE with 0.5% SDS for
15 mm at room temperature, in lx SSPE with 0.5% SDS
for 15 mm at room temperature, followed by 1 h at 65#{176}C,
and then with o.ix SSPE with 0.5% SDS for 30 mm at
65#{176}C. They were exposed to X-ray film (Kodak XAR-5)
with an intensifying screen at -70#{176}C.
The human TNF-a cDNA probe was isolated from a
plasmid containing a 800-base pair EcoRI fragment of
TNF-a cloned into a Sp64 vector (43). The cDNA probe
for DF was similarly isolated from a plasmid containing a
1-kilobase insert cloned as an EcoRl fragment in pUCl8
(44). The human M-CSF probe was obtained from a
plasmid containing a 2-kilobase cDNA fragment
(p3ACSFR) cloned into the XhoI/EcoRI site of pXm (45).
Probes were labeled by incubating the fragments with
[32P]CTP by the Multiprime method (Amersham Corp.,
Arlington Heights, IL) (46).
[3H]Leucine Radiolabeling. In some cultures, the bone
marrow stromal cell line was grown as described. The
matrix was isolated as before, and HL-60 cells were
seeded on matrix in fresh medium for a 3-day incubation.
Five zCi/ml [3H]leucine (53 Ci/mmol; Amersham) were
added to the medium at the time of seeding to monitor
protein production by the HL-60 cells. The medium was
harvested from the radiolabeled cultures as before and
tested for differentiating activity.
Gel Filtration Chromatography. CM (190 ml) was har-
vested from 19 flasks, precipitated with 50% ammonium
sulfate, and concentrated over a Mr of 10,000 Amicon
membrane. It was then applied in a 4.0-mI volume to a
Sephacryl S-200 column (103 x 2.5 cm) and eluted in 160
mM NaCI and 4 mM 4-(2-hydroxyethyl)-1-piperazmneeth-
anesulfonic acid, pH 7.4 (47). Fractions were collected
and filtered, and aliquots were added to fresh HL-60
cells, which were incubated for 3 days and tested for
maturation.
Ion-Exchange Chromatography. Active fractions from
the Sephacryl S-200 column were pooled, precipitated
with 50% ammonium sulfate, and concentrated over a
Mr 10,000 Amicon membrane. The retentate was sub-
jected to high-performance ion-exchange chromatogra-
phy using an LKB 2133-150 Ultrapac TSK 545 DEAE-
cellulose column (150 x 21.5 mm) equilibrated with 0.01
M NaCI in 0.01 M sodium phosphate, pH 7 (48). The
column was eluted with a 0.01 to 0.4 M NaCI linear
gradient, and salt concentrations in the fractions were
determined by conductivity. Fractions were concen-
trated, and salt was removed by application to a M,
10,000 Amicon membrane; differentiating activity was
then assessed.
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